DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Prochlorperazine is a drug marketed by Alpharma Us Pharms, Baxter Hlthcare, Able, Cosette, Watson Labs, Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus Pharms, Smith And Nephew, Teva Parenteral, West-ward Pharms Int, Wyeth Ayerst, Duramed Pharms Barr, Ivax Sub Teva Pharms, Mylan, Sandoz, and Teva Pharms. and is included in thirty-two NDAs.
The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.
A generic version of PROCHLORPERAZINE was approved as prochlorperazine maleate by MYLAN on October 28th, 1996.
Recent Clinical Trials for PROCHLORPERAZINE
Identify potential brand extensions & 505(b)(2) entrants
|National Institute on Drug Abuse (NIDA)||Phase 2|
|New York State Psychiatric Institute||Phase 2|
|Nova Southeastern University||Phase 4|
Pharmacology for PROCHLORPERAZINE
|Drug Class||Phenothiazine |